Impact News +++ Gescheiterte Anleihegespräche: Aktie von Exail Technologies bricht um 21 % ein (Investing.com DE) +++ EXAIL Aktie -17,61%

ECHO IQ Aktie

>ECHO IQ Aktienkurs

0.685 EUR -2.1% (TradegateBSX)

Ask: 0.712 EUR / 6924 Stück

Bid: 0.685 EUR / 7197 Stück

Tagesumsatz: 6000 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ECHO IQ Aktie über LYNX handeln

Intraday

1 Jahr

>ECHO IQ Performance

1 Woche: -14,2%

1 Monat: +13,0%

3 Monate: +41,0%

6 Monate: +398,6%

1 Jahr: 0%

laufendes Jahr: +386,2%

>ECHO IQ Aktie

Name:

ECHO IQ LTD.

Land:

Australien

Sektor:

Elektronik / Software

ISIN/ Wkn:

AU0000195430 / A3C84A

Symbol/ Ticker:

PL4 (Frankfurt)

Kürzel:

FRA:PL4, ETR:PL4, PL4:GR

Index:

Webseite:

https://www.echoiq.ai/

Profil:

Echo IQ Limited is an Australian-based artificial intelligence and medical technology company specializing in software solutions for the cardiac diagnostics sector. Its primary function is to develop and commercialize AI-powered tools that enhance th..
>Volltext..

Marktkapitalisierung:

485.16 Mio. EUR

Unternehmenswert:

478.82 Mio. EUR

Umsatz:

0.05 Mio. EUR

EBITDA:

-9.71 Mio. EUR

Nettogewinn:

-9.05 Mio. EUR

Gewinn je Aktie:

-0.01 EUR

Schulden:

Liquide Mittel:

6.46 Mio. EUR

Operativer Cashflow:

-4.77 Mio. EUR

Bargeldquote:

15.6

Umsatzwachstum:

-33.48%

Gewinnwachstum:

-68.39%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

ECHO IQ

Letzte Datenerhebung:

12.06.26

>ECHO IQ Kennzahlen

Aktien/ Unternehmen:

Aktien: 660.86 Mio. St.

Frei handelbar: 73.58%

Leerverk. Aktien: -

Rückkaufquote: -1.93%

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Strong buy

Kursziel: 18.43%

Bewertung:

KGV: -

KGV lG: -

KUV: 8560.48

KBV: 48.18

PEG-Ratio: -0.87

EV/EBITDA: -

Rentabilität:

Bruttomarge: -8303.71%

Gewinnmarge: -17277.21%

Operative Marge: -19154.17%

Managementeffizenz:

Gesamtkaprendite: -109.78%

Eigenkaprendite: -115.2%

>ECHO IQ Peer Group

Elektronik / Software, KI- Anwendungen, -Software & -Infrastruktur, Unternehmenssoftware (Business Software)

>ECHO IQ Chart & Kurs - Tradegate

>ECHO IQ News

12.06.26 - 06:01	Echo IQ teams up with Mayo Clinic to evaluate AI cardiac risk tool in cancer patients (Market Herald)
	Echo IQ (ASX: EIQ) has secured a research collaboration with Mayo Clinic…...

12.06.26 - 02:12	Echo IQ Secures Mayo Clinic Collaboration to Assess Cardiac Risk in Cancer Patients (Small Caps)
	Echo IQ teams with Mayo Clinic Arizona to test AI-driven cardiac risk scores from echocardiography in cancer patients; results expected 2027....

30.04.26 - 22:06	Echo IQ Announces EchoSolv AS Deployed into Mount Sinai Health System (GlobeNewswire EN)
	SYDNEY, April 30, 2026 (GLOBE NEWSWIRE) -- AI and Medical Technology company Echo IQ (“the Company”) (ASX: EIQ) is pleased to advise it has deployed its AI-based decision support software for the assessment of severe aortic stenosis, EchoSolv™ AS, with Mount Sinai Health System in New York, USA....

24.03.26 - 02:24	Echo IQ Expands Agreement with Mayo Clinic for Distribution of EchoSolv HF (Small Caps)
	Echo IQ expands Mayo Clinic distribution for EchoSolv HF; FDA clearance pending, auto-renew 3 years, unlocking Mayo Clinic Platform (MCP) network....

24.11.25 - 15:24

Validation study for EchoSolv HF completed at the Mayo Clinic – Study delivers exceptional results (GlobeNewswire EN)

SYDNEY, Nov. 24, 2025 (GLOBE NEWSWIRE) -- AI and Medical Technology Company Echo IQ Limited (ASX: EIQ) (“Echo IQ” or “the Company”) is pleased to advise that it has completed its clinical validation for its heart failure clinical decision support software (“EchoSolv HF”) in collaboration with the Mayo Clinic Platform (“MCP”), a division of the Mayo Clinic, a top ranked US hospital. The MCP Validate program is a unique in-market AI evaluation program which generates an independent and objective report on accuracy, efficacy and susceptibility to bias for AI-based decision software (refer ASX Announcement 1 July 2025)....

21.11.25 - 22:09

Echo IQ to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire EN)

SYDNEY, Nov. 21, 2025 (GLOBE NEWSWIRE) -- AI and Medical Technology company Echo IQ (“the Company” or “Echo IQ”) (ASX: EIQ), today announced that Dustin Haines, Chief Executive Officer, will participate in a fireside chat at the upcoming Piper Sandler 37th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 2, 2025, at 12:50 p.m. Eastern Time....

02.10.25 - 06:24

Echo IQ Reports Strong US Performance of EchoSolv AS Platform Ahead of Regulatory Clearance (Small Caps)

Perth-based medical technology company Echo IQ (ASX: EIQ) has reported strong operational momentum from its EchoSolv AS platform in the US market, with a 153% increase in echocardiograms over the three months to September. The performance has come about through extensive engagement with US hospital groups, which have integrated the technology into their operations, resulting in the […] The post Echo IQ Reports Strong US Performance of EchoSolv AS Platform Ahead of Regulatory Clearance appeared first on Small Caps....

26.06.25 - 00:09	XFRA: NEW INSTRUMENT AVAILABLE - 26.06.2025 - EQUBF_01 (XETRA)
	Das Instrument PL4 AU0000195430 ECHO IQ LTD. EQUITY hat seinen ersten Handelstag am 26.06.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N The instrument PL4 AU0000195430 ECHO IQ LTD. EQUITY has its first trading date on 26.06.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Es liegt nun einmal in meiner Natur: ich will lieber eine Ungerechtigkeit begehen, als Unordnung ertragen. - Johann Wolfgang von Goethe

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram